Additional $25M in Milestones
Cornerstone Diversifies Hospital Portfolio, Buys EKR for $125M
By Marie Powers
Wednesday, May 16, 2012
Cornerstone Therapeutics Inc., which has taken some interesting turns on the road to building a portfolio of hospital and respiratory products, expanded its acute care franchise with an agreement to acquire EKR Therapeutics Inc., which specializes in drugs used in the critical care setting.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.